FAP and cancer: These results suggest an early migration of cancer cells from FAP positive primary tumors to lymph nodes, and could explain, at least in part, both the shorter survival outcome of mCCRCC with lymph node metastases [19,26] and also the relationship between FAP expression and worse prognosis of mCCRCC patients.